MedTrace Logo

Clinical Trial of Tensegrity Prosthetics K3 Promoter Foot Prosthesis

NCT00888199 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-04-27

No results posted yet for this study

Summary

The purpose of this clinical trial is to determine if the experimental Tensegrity prosthetic foot offers a reduction of the amount of oxygen used while walking, if stability is improved over current prosthetic feet, and whether the experimental device actually increases activity in amputees.

Conditions

  • Amputation

Interventions

DEVICE

Experimental prosthetic foot (K3 Promoter)

Experimental prosthetic foot

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Tensegrity Prosthetics

    lead INDUSTRY

Principal Investigators

  • Jerome Rifkin, MS ME · Tensegrity Prosthetics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888199 on ClinicalTrials.gov